BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32845232)

  • 1. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials.
    Lew JB; Greuter MJE; Caruana M; He E; Worthington J; St John DJ; Macrae FA; Feletto E; Coupé VMH; Canfell K
    Med Decis Making; 2020 Aug; 40(6):815-829. PubMed ID: 32845232
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.
    Buskermolen M; Gini A; Naber SK; Toes-Zoutendijk E; de Koning HJ; Lansdorp-Vogelaar I
    Med Decis Making; 2018 Nov; 38(8):917-929. PubMed ID: 30343626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.
    Shroff J; Thosani N; Batra S; Singh H; Guha S
    World J Gastroenterol; 2014 Dec; 20(48):18466-76. PubMed ID: 25561818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.
    Pinsky PF; Loberg M; Senore C; Wooldrage K; Atkin W; Bretthauer M; Cross AJ; Hoff G; Holme O; Kalager M; Segnan N; Schoen RE
    Gastroenterology; 2018 Oct; 155(4):1059-1068.e2. PubMed ID: 29935150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Colorectal Cancer Models on Long-term Outcomes from a Randomized Controlled Trial.
    DeYoreo M; Lansdorp-Vogelaar I; Knudsen AB; Kuntz KM; Zauber AG; Rutter CM
    Med Decis Making; 2020 Nov; 40(8):1034-1040. PubMed ID: 33078673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
    Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
    Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
    Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
    BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.
    Elmunzer BJ; Hayward RA; Schoenfeld PS; Saini SD; Deshpande A; Waljee AK
    PLoS Med; 2012; 9(12):e1001352. PubMed ID: 23226108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks.
    Vahdat V; Alagoz O; Chen JV; Saoud L; Borah BJ; Limburg PJ
    Med Decis Making; 2023 Aug; 43(6):719-736. PubMed ID: 37434445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
    Swartz AW; Eberth JM; Strayer SM
    Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
    Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
    J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model.
    Heisser T; Hoffmeister M; Brenner H
    Int J Cancer; 2021 Apr; 148(8):1973-1981. PubMed ID: 33320964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based microsimulation model for colorectal cancer: validation and application.
    Rutter CM; Savarino JE
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1992-2002. PubMed ID: 20647403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Doroudi M; Schoen RE; Pinsky PF
    Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.